Estimation of the odds ratio in a proportional odds model with censored time-lagged outcome in a randomized clinical trial

06/29/2021
by   Anastasios A. Tsiatis, et al.
0

In many randomized clinical trials of therapeutics for COVID-19, the primary outcome is an ordinal, categorical variable for which the final category is often death, which can be ascertained at the time of occurence. For the remaining categories, determination of into which of these categories a participant's outcome falls cannot be made until some ascertainment time that can be less than or equal to a pre-specified follow-up time. Interest focuses on the odds ratio (active agent vs. control) under the assumption of a proportional odds model. Although at the final analysis the outcome will be determined for all subjects, at an interim analysis, the status of some participants may not yet be determined; accordingly, the outcome from these subjects can be viewed as censored. A valid interim analysis can be based on data only from those subjects with full follow up; however, this approach is inefficient, as it does not exploit additional information that may be available on those who have not reached the follow-up time at the time of the interim analysis. Appealing to the theory of semiparametrics, we propose an estimator for the odds ratio in a proportional odds model with censored, time-lagged categorical outcome that incorporates such additional baseline and time-dependent information and demonstrate that it can result in considerable gains in efficiency relative to simpler approaches.

READ FULL TEXT
research
04/22/2022

Group sequential methods for interim monitoring of randomized clinical trials with time-lagged outcome

The primary analysis in two-arm clinical trials usually involves inferen...
research
04/08/2022

Long-term effect estimation when combining clinical trial and observational follow-up datasets

Combining experimental and observational follow-up datasets has received...
research
02/28/2018

Sample size for a non-inferiority clinical trial with time-to-event data in the presence of competing risks

The analysis and planning methods for competing risks model have been de...
research
08/17/2022

Natural cubic splines for the analysis of Alzheimer's clinical trials

Mixed model repeated measures (MMRM) is the most common analysis approac...
research
11/25/2020

Unstructured Primary Outcome in Randomized Controlled Trials

The primary outcome of Randomized clinical Trials (RCTs) are typically d...
research
11/07/2020

GP-LVM of categorical data from test-positive COVID-19 pregnant women

Novel coronavirus disease 2019 (COVID-19) is rapidly spreading throughou...
research
03/24/2019

Correct power for cluster-randomized difference-in-difference trials with loss to follow-up

Cluster randomized trials with measurements at baseline can improve powe...

Please sign up or login with your details

Forgot password? Click here to reset